Cite Filings / STOK / 0001193125-26-108362
Feed Companies Filings Check
Sign in
10-K

Annual Report

Stoke Therapeutics, Inc. · Filed 2026-03-16 · Acc 0001193125-26-108362

Documents 1

  • 10-K Annual Report , stok-20251231.htm

Around this filing

  • 2026-03-17 4 CHIEF MEDICAL OFFICER acquired 33,850 shares (option exercise)
  • 2026-03-17 4 Chief Financial Officer acquired 14,750 shares (option exercise)
  • 2026-03-17 4 Chief Patient Officer acquired 10,000 shares (option exercise)
  • 2026-03-17 4 Director acquired 61,750 shares (option exercise)
  • 2026-03-16 S-8 Securities Offered to Employees in Benefit Plans
  • 2026-03-16 10-K Annual Report
  • 2025-03-18 10-K Annual Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading stok-20251231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…